Status:
TERMINATED
A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Pain
Eligibility:
All Genders
18-59 years
Phase:
PHASE3
Brief Summary
Comparing the short-term efficacy of rofecoxib versus placebo. Patients receive rofecoxib or placebo or diclofenac and fill out a patient diary on daytime pain severity during daily activities, night ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Males or females between the ages of 18 and 59 with acute painful rotator cuff syndrome.
Exclusion
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT00140933
Start Date
April 1 2003
Last Update
December 5 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoires Merck Sharp & Dohme - Chibret
Paris, France, 75114